| NCT06756035 | CT-95 in Advanced Cancers Associated With Mesothelin Expression | RECRUITING | PHASE1 | 2025-03-31 | 2028-12 | 2026-12 |
| NCT06515613 | A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors | RECRUITING | PHASE1 | 2024-07-10 | 2028-03-31 | 2027-07-30 |
| NCT06938711 | A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer | WITHDRAWN | PHASE1, PHASE2 | 2023-06 | 2023-12 | 2023-11 |
| NCT05618613 | Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer | TERMINATED | PHASE1, PHASE2 | 2022-12-02 | 2023-06-23 | 2023-06-23 |